NanoLogix, Inc. is a biotechnology company, which engages in the research, development, commercialization, and production of filled Petri plates and rapid diagnostic test kits that detect viable bacteria and other microorganisms. The company is headquartered in Hubbard, Ohio. The company went IPO on 2001-07-20. The firm's key areas of interest are Bio Nanopores, Anthrax Detections, Petri Dishes, Highly Specializeds, Permeables, Membranes, Translucents, Nutrients, Nutrient Agars, Impermeable Cells, Hydrophilics, Isolation, Cultivations, Varieties, Fastidious, Nonfastidious, Anaerobic Microogranisms, Total Plate Counts, Biotechnology, Detect Viable Bacteria, Petri Culture Technology, Cleanrooms, Quick Tests, Mrsas, Group B Streps, Salmonellas, Listerias, Single Cells. The firm was founded in 1989.